137
Views
1
CrossRef citations to date
0
Altmetric
Special Report

Potential for Stem Cell Use in Congenital Heart Disease

&
Pages 161-169 | Published online: 14 Mar 2012

References

  • Leri A , KajsturaJ, AnversaP. Role of cardiac stem cells in cardiac pathophysiology: a paradigm shift in human myocardial biology. Circ. Res., 109(8), 941–946 (2011).
  • Wollert KC , MeyerGP, LotzJet al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet , 364, 141–148 (2004).
  • Wollert KC , DrexlerH. Clinical applications of stem cells for the heart. Circ. Res., 96, 151–163 (2005).
  • Dolk H , LoaneM, GarneE. The prevalence of congenital anomalies in Europe. Adv. Exp. Med. Biol., 686, 349–364 (2010).
  • Vrtovec B , PoglajenG, SeverM. Effects of intracoronary stem cell transplantation in patients with dilated cardiomyopathy. J. Cardiac Fail., 17(4), 272–281 (2011).
  • Arguero R , Careaga-ReynaG, Castano-GuerraR. Cellular autotransplantation for ischemic and idiopathic dilated cardiomyopathy. Preliminary report. Arch. Med. Res., 37, 1010–1014 (2006).
  • Strauer BE , YousefM, SchannwellCM. The acute and long-term effects of intracoronary stem cell transplantation in 191 patients with chronic heart failure: the STAR heart study. Eur. J. Heart Fail., 12, 721–729 (2010).
  • Rupp S , BauerJ, TonnT. Intracoronary administration of autologous bone marrow-derived progenitor cells in a critically ill two-yr-old-child with dilated cardiomyopathy. Pediatr. Transplant., 13, 620–623 (2009).
  • Rupp S , ZeiherAM, DimmelerSet al. A regenerative strategy for heart failure in hypoplastic left heart syndrome: Intracoronary administration of autologous bone marrow-derived progenitor cells. J. Heart Lung Transplant. , 29(5), 574–577 (2010).
  • Pathak S , LeesC. Ultrasound structural fetal anomaly screening: an update. Arch. Dis. Child. Fetal Neonatal Ed., 94, F384–F390 (2009).
  • Marek J , TomekV, ŠkovránekJ, PovýšilováV, ŠamánekM. Prenatal ultrasound screening of congenital heart disease in an unselected national population: a 21-year experience. Heart, 97, 124–130 (2011).
  • Shaw SW , BolliniS, NaderKA, GastadelloAet al. Autologous transplantation of amniotic fluid-derived mesenchymal stem cells into sheep fetuses. Cell Transplant. , 20, 1015–1031 (2011).
  • Wang F , GuanJ. Cellular cardiomyoplasty and cardiac tissue engineering for myocardial therapy. Adv. Drug Deliv. Rev., 62, 784–797 (2010).
  • Mathur A , MartinJF. Stem cells and repair of the heart. Lancet, 364, 183–192 (2004).
  • Menasché P , AlfieriO, JanssensSet al. The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) Trial. First randomized placebo-controlled study of myoblast transplantation. Circulation , 117, 1189–1200 (2008).
  • Lunde K , SolheimS, AakhusS, ArnesenH, AbdelnoorM, ForfangK. Autologous stem cell transplantation in acute myocardial infarction: the ASTAMI randomized controlled trial. Intracoronary transplantation of autologos mononuclear bone marrow cells, study design and safety aspects. Scand. Cardiovasc. J., 39(3), 150–158 (2005).
  • Liras A . Future research and therapeutic applications of human stem cells: general, regulatory, and bioethical aspects. J. Transl. Med., 8, 131 (2010).
  • Rao M , CondicML. Alternative sources of pluripotent stem cells: scientific solutions to an ethical dilemma. Stem Cells Dev., 17, 1–10 (2008).
  • Hyun I . The bioethics of stem cell research and therapy. J. Clin. Invest., 120, 71–75 (2010).
  • Sandel MJ . Embryo ethics – the moral logic of stem-cell research. N. Eng. J. Med., 351(3), 207–209 (2004).
  • Jezierska-Wozniak K , MystkowskaD, TutasA, JurkowskiMK. Stem cells as therapy for cardiac disease – a review. Folia Histochem. Cytobiol., 49(1), 13–25 (2011).
  • Krane M , WerenetO, WuSM. Promises and pitfalls in cell replacement therapy for heart failure. Drug Discov. Today Dis. Mech., 7(2), e109–e115 (2010).
  • Okita K , NagataN, YamanakaS. Immunogenicity of induced pluripotent stem cells. Circ. Res., 109, 720–721 (2011).
  • Egashira T , YuasaS, FukudaK. Induced pluripotent stem cells in cardiovascular medicine. Stem Cells Int., 2011, 348960 (2011).
  • Iyer RK , ChiuLLY, ReisLA, RadisicM. Engineered cardiac tissue. Curr. Opin. Biotechnol., 22(5), 706–714 (2011).
  • Bollini S , SmartN, RileyPR. Resident cardiac progenitor cells: at the heart of regeneration. J. Mol. Cell. Cardiol., 50(2), 296–303 (2011).
  • Smart N , RileyPR. The stem cell movement. Circ. Res., 102, 1155–1168 (2008).
  • Weber B , ZeisbergerSM, HoerstrupSP. Prenatally harvested cells for cardiovascular tissue engineering: Fabrication of autologous implants prior to birth. Placenta, 32(4), S316–S319 (2011).
  • Planat-Bénard V , MenardC, AndréMet al. Spontaneous cardiomyocyte differentiation from adipose tissue stroma cells. Circ. Res. , 94, 223–229 (2004).
  • Choi YS , DustingGJ, StubbsSet al. Differentiation of human adipose-derived stem cells into beating cardiomyocytes. J. Cell. Mol. Med. , 14(4), 878–889 (2010).
  • Wu KH , HanZC, MoXM, ZhouB. Cell delivery in cardiac regenerative therapy. Ageing Res. Rev., 11(1), 32–40 (2011).
  • Klein HM , GhodsizadA, MarktannerRet al. Intramyocardial implantation of CD133+ stem cells improved cardiac function without bypass surgery. Heart Surg. Forum , 10(1), E66–E69 (2007).
  • Boomsma RA , SwaminathanPD, GeenenDL. Intravenously injected mesenchymal stem cells home to viable myocardium after coronary occlusion and preserve systolic function without altering infarct size. Int. J. Cardiol., 122(1), 17–28 (2007).
  • Hare JM , TraverseJH, HenryTDet al. A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. J. Am. Coll. Cardiol. , 54(24), 2277–2286 (2009).
  • Quaini F , UrbanekK, BeltramiAPet al. Chimerism of the transplanted heart. N. Engl. J. Med. , 346(1), 5–15 (2002).
  • Dimmeler S , Vasa-NicoteraM. Aging of progenitor cells: limitation for regenerative capacity? J. Am. Coll. Cardiol., 42, 2081–2082 (2003).
  • Langer R , VacantiJP. Tissue engineering. Science, 260(5110), 920–926 (1993).
  • Wang C , VarshneyRR, WangD. Therapeutic cell delivery and fate control in hydrogels and hydrogel hybrids. Adv. Drug Deliv. Rev., 62(7–8), 699–710 (2010).
  • Fujimoto KL , MaZ, NelsonDMet al. Synthesis, characterization and therapeutic efficacy of a biodegradable, thermoresponsive hydrogel designed for application in chronic infarcted myocardium. Biomaterials , 30, 4357–4368 (2009).
  • Martinez EC , KofidisT. Adult stem cells for cardiac tissue engineering. J. Mol. Cell. Cardiol., 50, 312–319 (2011).
  • Davis DR , SmithRR, MarbánE. Stem cell technology: epigenetics, genomics, proteomics and metabonomics. Stem Cells, 28, 903–904 (2010).
  • Zakharova L , MastroeniD, MutluNet al. Transplantation of cardiac progenitor cell sheet onto infarcted heart promotes cardiogenesis and improves function. Cardiovasc. Res. , 87, 40–49 (2010).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.